Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110,975 | 70 | 84.4% |
| Food and Beverage | $10,446 | 299 | 7.9% |
| Travel and Lodging | $3,787 | 27 | 2.9% |
| Consulting Fee | $3,345 | 2 | 2.5% |
| Education | $3,001 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $75,246 | 129 | $0 (2024) |
| GlaxoSmithKline, LLC. | $38,336 | 134 | $0 (2021) |
| Amgen Inc. | $4,899 | 8 | $0 (2022) |
| Mylan Specialty L.P. | $4,716 | 12 | $0 (2018) |
| INTUITIVE SURGICAL, INC. | $3,386 | 10 | $0 (2024) |
| Acerta Pharma LLC | $1,959 | 2 | $0 (2021) |
| ViiV Healthcare Company | $600.00 | 1 | $0 (2019) |
| bioMerieux Inc | $345.18 | 1 | $0 (2022) |
| United Therapeutics Corporation | $300.02 | 4 | $0 (2017) |
| Genentech USA, Inc. | $238.97 | 16 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,292 | 12 | AstraZeneca Pharmaceuticals LP ($7,114) |
| 2023 | $4,444 | 12 | AstraZeneca Pharmaceuticals LP ($4,108) |
| 2022 | $19,579 | 28 | AstraZeneca Pharmaceuticals LP ($13,239) |
| 2021 | $16,608 | 17 | GlaxoSmithKline, LLC. ($7,441) |
| 2020 | $7,656 | 10 | GlaxoSmithKline, LLC. ($5,825) |
| 2019 | $40,584 | 67 | GlaxoSmithKline, LLC. ($23,957) |
| 2018 | $23,118 | 103 | AstraZeneca Pharmaceuticals LP ($17,660) |
| 2017 | $12,274 | 151 | AstraZeneca Pharmaceuticals LP ($10,189) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $120.62 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $77.84 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: SURGERY | ||||||
| 04/23/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: SURGERY | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $40.85 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $83.34 | General |
| Category: SURGERY | ||||||
| 02/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $63.75 | General |
| Category: SURGERY | ||||||
| 12/19/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 10/17/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Education | In-kind items and services | $0.70 | General |
| Category: Respiratory | ||||||
| 09/12/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: SURGERY | ||||||
| 09/12/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: SURGERY | ||||||
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: NEUROLOGY | ||||||
| 04/11/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: SURGERY | ||||||
| 03/21/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 03/16/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $35.41 | General |
| Category: Respiratory | ||||||
| 02/21/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $119.38 | General |
| Category: SURGERY | ||||||
| 12/20/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 928 | 1,276 | $264,884 | $94,351 |
| 2022 | 17 | 877 | 1,185 | $233,823 | $85,958 |
| 2021 | 15 | 884 | 1,237 | $227,825 | $90,931 |
| 2020 | 19 | 971 | 1,332 | $261,003 | $92,470 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 198 | $46,926 | $19,558 | 41.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 175 | $40,075 | $17,057 | 42.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 253 | $39,974 | $16,554 | 41.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 45 | $40,590 | $7,554 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 107 | $17,227 | $7,324 | 42.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 39 | $11,895 | $5,686 | 47.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 35 | $15,190 | $4,853 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $12,780 | $4,722 | 36.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 40 | $11,760 | $4,225 | 35.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 19 | $5,757 | $1,910 | 33.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 22 | $4,730 | $1,533 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,146 | $1,156 | 36.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 100 | 105 | $6,090 | $732.74 | 12.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 69 | 69 | $5,106 | $655.95 | 12.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 77 | 83 | $2,158 | $535.20 | 24.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 36 | 37 | $1,480 | $296.17 | 20.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 240 | $54,960 | $19,947 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 149 | $35,313 | $14,389 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 135 | $21,735 | $9,381 | 43.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 160 | $25,280 | $9,355 | 37.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 29 | 34 | $22,818 | $6,353 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $12,586 | $5,186 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $13,135 | $5,048 | 38.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 43 | $12,642 | $5,031 | 39.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 27 | 31 | $8,783 | $2,859 | 32.6% |
About Dr. Daniel Gerardi, MD
Dr. Daniel Gerardi, MD is a Pulmonary Disease healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1538167424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Gerardi, MD has received a total of $131,554 in payments from pharmaceutical and medical device companies, with $7,292 received in 2024. These payments were reported across 400 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($110,975).
As a Medicare-enrolled provider, Gerardi has provided services to 3,660 Medicare beneficiaries, totaling 5,030 services with total Medicare billing of $363,711. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Hartford, CT
- Active Since 07/13/2005
- Last Updated 02/24/2009
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1538167424
Products in Payments
- FASENRA (Drug) $33,711
- TRELEGY ELLIPTA (Drug) $31,841
- TEZSPIRE (Biological) $18,619
- FASENRA (Biological) $12,945
- BEVESPI AEROSPHERE (Drug) $10,733
- ANORO (Drug) $5,349
- Yupelri (Drug) $4,701
- ION (Device) $3,000
- Da Vinci Surgical System (Device) $386.32
- NephroCheck Test Kit (Device) $345.18
- ANORO ELLIPTA (Drug) $311.79
- BREO (Drug) $310.03
- ORENITRAM (Drug) $300.02
- NUCALA (Biological) $233.05
- superDimension (Device) $164.46
- INSPIRE (Device) $144.09
- Esbriet (Biological) $122.61
- Xolair (Biological) $116.36
- SYMBICORT (Drug) $105.56
- STIOLTO (Drug) $101.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hartford
James Pope, Md, MD
Pulmonary Disease — Payments: $59,197
Eric Shore, Md, MD
Pulmonary Disease — Payments: $38,225
John Russomanno, Md, MD
Pulmonary Disease — Payments: $16,927
Richard Zuwallack, Md, MD
Pulmonary Disease — Payments: $6,630
Phyllis Schatz, Md, MD
Pulmonary Disease — Payments: $5,543
Prashant Grover, M.d, M.D
Pulmonary Disease — Payments: $4,099